What should you know about FDA-approved exosomes?

Exosomes are small membrane-bound particles released by cells and may carry proteins or other biological signals. A product’s composition can depend on its source, processing, storage, and route of administration. A clinic’s claim about approval may refer to a device, a procedure, or a different product rather than the exosome preparation itself. Marketing language about skin renewal, hair, scars, or inflammation should therefore be separated from what has been specifically authorised for the proposed use.

Ask for the product name, manufacturer, source material, sterility controls, storage requirements, route, and intended use. Ask whether the treatment is injected, applied after a procedure, or delivered by another method. Discuss allergies, immune conditions, active infection, pregnancy or breastfeeding, medicines, and previous reactions. Get a clear explanation of what is known, what is uncertain, and how complications would be managed. Read the dedicated Exosomes explainer before consenting, and be cautious when a provider cannot answer basic product questions.

After treatment, seek prompt medical advice for worsening redness, warmth, swelling, pain, drainage, fever, hives, breathing difficulty, or facial swelling. Urgent care is appropriate for severe weakness, confusion, fainting, or rapidly worsening symptoms. Keep the product details and treatment date available so a clinician can identify what was administered or applied.

What exact product is this, and what is its source? What approval or authorisation applies to this product and route? What evidence supports my proposed use? How are sterility and storage handled, and who will manage a reaction?